Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx
Zachary Risch(University of Michigan), Francis P. Worden(Georgetown University), Keith Casper(University of Michigan), Kelly M. Malloy(University of Michigan), Mark E. Prince(University of Michigan), Carol R. Bradford(The Ohio State University), Emily L. Bellile(University of Michigan), Moneb Bughrara(University of Michigan), Paul Swiecicki(University of Michigan), Andrew G. Shuman(University of Michigan), Matthew E. Spector(Michigan Medicine), Shruti Jolly(University of Michigan), Thomas E. Carey(University of Michigan), Michelle Mierzwa(University of Michigan), Norman D. Hogikyan(Michigan Medicine), Gregory T. Wolf(University of Michigan), Chaz L. Stucken(Icahn School of Medicine at Mount Sinai), Steven B. Chinn(Pediatrics and Genetics), Avraham Eisbruch(University of Michigan–Ann Arbor)
Cited by 0
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Validation of an instrument to measure voice-related quality of life (V-RQOL)
|Journal of Voice|1999|1.1k
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
|New England Journal of Medicine|2020|766